ANKRD60: A Potential Drug Target and Biomarker (G140731)

Target Name: ANKRD60

NCBI ID: G140731

ANKRD60

ANKRD60: A Potential Drug Target and Biomarker

Ankyrin repeat domain-containing protein 60 (ANKRD60) is a protein that has been identified as a potential drug target and biomarker for various diseases, including neurodegenerative disorders, diabetes, and cancer. ANKRD60 is a member of the ANKRIN repeat protein family, which is characterized by the presence of a unique ANKRIN repeat in the extracellular domain of the protein. The ANKRIN repeat has been shown to play a critical role in the regulation of various cellular processes, including cell signaling, DNA replication, and protein stability.

One of the unique features of ANKRD60 is its ability to interact with various signaling pathways, including the TGF-β pathway. The TGF-β pathway is a well-established pathway that plays a critical role in the regulation of cell growth, differentiation, and survival, and is involved in the development and progression of many diseases, including neurodegenerative disorders. The TGF-β pathway is also implicated in the regulation of ANKRD60 function, as studies have shown that ANKRD60 can interact with TGF-β signaling pathway components, including the transcription factor Smad6.

In addition to its potential role in the TGF-β pathway, ANKRD60 has also been shown to interact with several other signaling pathways, including the PI3K/AKT signaling pathway, the NF-kappa-B signaling pathway, and the T-cell signaling pathway. These interactions suggest that ANKRD60 may have a wide range of potential functions, including the regulation of cellular signaling pathways that are involved in the development and progression of various diseases.

As a potential drug target, ANKRD60 is of particular interest because of its involvement in the regulation of cellular processes that are involved in the development and progression of many diseases, including neurodegenerative disorders. For example, studies have shown that ANKRD60 is involved in the regulation of neurotransmitter release from axons in the central nervous system, which is thought to play a role in the development of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. In addition, ANKRD60 has also been shown to play a role in the regulation of neuronal excitability, which is thought to be involved in the pathophysiology of many psychiatric and neurological disorders.

As a potential biomarker, ANKRD60 is of particular interest because of its ability to serve as a target for small molecules that can modulate its function. This is an attractive property for biomarkers because it allows for the development of small molecule-based therapies that can be targeted to specific diseases. For example, studies have shown that ANKRD60 can be modulated by small molecules such as inhibitors of the TGF-β pathway, which are of particular interest as potential therapeutic compounds for the treatment of neurodegenerative disorders.

In conclusion, ANKRD60 is a protein that has been identified as a potential drug target and biomarker for various diseases. Its unique ability to interact with multiple signaling pathways, including the TGF-β pathway, makes it an attractive target for small molecules that can modulate its function. Further studies are needed to fully understand the role of ANKRD60 in the regulation of cellular processes and its potential as a drug target and biomarker.

Protein Name: Ankyrin Repeat Domain 60

The "ANKRD60 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ANKRD60 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets